Bülent Kara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bülent Kara has a total of 354 co-authors. Here are the top co-authors by number of shared publications:
- Mesut Güngör
Kocaeli Universitesi Tip Fakultesi
11 shared publications - Ayfer Sakarya Güneş
Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey
10 shared publications - Leman Tekin Orgun
Department of Pediatric Neurology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey
10 shared publications - Adnan Deniz
Department of Pediatric Neurology, Faculty of Medicine, Kocaeli University, 41001 Kocaeli, Türkiye
8 shared publications - Anıl Gök
Division of Child Neurology, Department of Pediatrics, Faculty of Medicine, Kocaeli University, Kocaeli, Türkiye
6 shared publications - Yonca Anik
Department of Radiology, Kocaeli University, Kocaeli, Turkey
5 shared publications
Latest Publications
- 6 November 2026
- Published by Springer Nature in Journal of Human Genetics
- p. 1-10
Expanding mutational landscape and clinical phenotype of the CASK-related neurological disorders
CASK-related disorders comprise two main phenotypes: severe microcephaly with pontocerebellar hypoplasia (MICPCH), typically caused by truncating variants, and milder X-linked intellectual disability (XLID), usually associated with missense variants. We aimed to characterize this molecular spectrum within an underrepresented national cohort. We evaluated 18 affected individuals from 16 unrelated families with CASK variants identified through exome or genome sequencing. Clinical, neurodevelopmental and neuroimaging findings were systematically reviewed. Selected missense variants were evaluated by in silico prediction tools and structural modeling. We identified 16 distinct CASK variants, 11 of which are novel, including frameshift, stop-gain, splice-site, and missense variants, as well as one large deletion. Consistent with known genotype-phenotype correlations, null alleles resulted in the severe MICPCH phenotype, while presumed hypomorphic alleles were associated with XLID. However, unlike previous reports, our MICPCH patients exhibited a higher frequency of dysmorphic facial features (86%), skeletal anomalies (57%) and sensorineural hearing loss (43%). Furthermore, contrary to the literature suggesting a milder epilepsy in females due to X-inactivation, 63% of our female patients with MICPCH presented with recurrent seizures. This cohort broadens both the molecular and phenotypic spectrum of CASK-related disorders. Findings reinforce that truncating variants predominantly cause MICPCH, while missense variants can lead to various outcomes depending on domain-level structural impact. We demonstrate that the CASK phenotypic spectrum is broader than previously recognized, frequently involving distinctive facial dysmorphism, skeletal defects and hearing impairment, suggesting that CASK plays a critical role not only in synaptic function but also in wider developmental processes.
- 6 November 2026
- Published by Springer Nature in Journal of Human Genetics
- p. 1-10
Expanding mutational landscape and clinical phenotype of the CASK-related neurological disorders
CASK-related disorders comprise two main phenotypes: severe microcephaly with pontocerebellar hypoplasia (MICPCH), typically caused by truncating variants, and milder X-linked intellectual disability (XLID), usually associated with missense variants. We aimed to characterize this molecular spectrum within an underrepresented national cohort. We evaluated 18 affected individuals from 16 unrelated families with CASK variants identified through exome or genome sequencing. Clinical, neurodevelopmental and neuroimaging findings were systematically reviewed. Selected missense variants were evaluated by in silico prediction tools and structural modeling. We identified 16 distinct CASK variants, 11 of which are novel, including frameshift, stop-gain, splice-site, and missense variants, as well as one large deletion. Consistent with known genotype-phenotype correlations, null alleles resulted in the severe MICPCH phenotype, while presumed hypomorphic alleles were associated with XLID. However, unlike previous reports, our MICPCH patients exhibited a higher frequency of dysmorphic facial features (86%), skeletal anomalies (57%) and sensorineural hearing loss (43%). Furthermore, contrary to the literature suggesting a milder epilepsy in females due to X-inactivation, 63% of our female patients with MICPCH presented with recurrent seizures. This cohort broadens both the molecular and phenotypic spectrum of CASK-related disorders. Findings reinforce that truncating variants predominantly cause MICPCH, while missense variants can lead to various outcomes depending on domain-level structural impact. We demonstrate that the CASK phenotypic spectrum is broader than previously recognized, frequently involving distinctive facial dysmorphism, skeletal defects and hearing impairment, suggesting that CASK plays a critical role not only in synaptic function but also in wider developmental processes.
- Open Access
- 24 October 2026
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 68 (5) , 882-888
Perineal dysmorphism and patellar luxation in SLC35A2-CDG: a new piece in the glycosylation puzzle
Background. Congenital disorders of glycosylation (CDG) represent a group of inherited metabolic diseases characterized by multisystem involvement. SLC35A2-CDG (OMIM #300896) is a rare X-linked subtype resulting from pathogenic variants in the SLC35A2 gene, which encodes the UDP-galactose transporter. Approximately 70 cases have been documented, predominantly presenting with early-onset epilepsy, developmental delay, hypotonia, and dysmorphic features. Phenotypic variability remains incompletely characterized, and novel features continue to expand the clinical spectrum. Case Presentation. We report a 6-year-old girl with SLC35A2-CDG harboring a novel de novo heterozygous frameshift variant (NM_005660.3: c.105_106insCG, p.K36Rfs*6). The patient presented with epileptic spasms, severe global developmental delay, hypotonia, and distinctive dysmorphic features including strabismus and inverted nipples. Notably, she exhibited bilateral patellar luxation and perineal dysmorphism with a shortened anogenital distance, features that have not been previously associated with SLC35A2-CDG. Additional findings included a thin corpus callosum, a pineal cyst, right-sided aortic arch, bilateral vesicoureteral reflux, and central hypothyroidism. Oral D-galactose supplementation was initiated and resulted in subjective improvements in language comprehension, pain responsiveness, and motor function, although no improvement in seizures was observed. Conclusions. This casa may expand the phenotypic spectrum of SLC35A2-CDG by describing bilateral patellar luxation and perineal dysmorphism as potentially novel clinical features, along with a previously unreported pathogenic variant. Recognition of such unique features is crucial for improving our clinical understanding of this rare disorder, guiding differential diagnosis, and contributing to a more refined characterization of genotype–phenotype correlations.
- 24 October 2026
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 68 (5) , 882-888
Open AccessPerineal dysmorphism and patellar luxation in SLC35A2-CDG: a new piece in the glycosylation puzzle
Background. Congenital disorders of glycosylation (CDG) represent a group of inherited metabolic diseases characterized by multisystem involvement. SLC35A2-CDG (OMIM #300896) is a rare X-linked subtype resulting from pathogenic variants in the SLC35A2 gene, which encodes the UDP-galactose transporter. Approximately 70 cases have been documented, predominantly presenting with early-onset epilepsy, developmental delay, hypotonia, and dysmorphic features. Phenotypic variability remains incompletely characterized, and novel features continue to expand the clinical spectrum. Case Presentation. We report a 6-year-old girl with SLC35A2-CDG harboring a novel de novo heterozygous frameshift variant (NM_005660.3: c.105_106insCG, p.K36Rfs*6). The patient presented with epileptic spasms, severe global developmental delay, hypotonia, and distinctive dysmorphic features including strabismus and inverted nipples. Notably, she exhibited bilateral patellar luxation and perineal dysmorphism with a shortened anogenital distance, features that have not been previously associated with SLC35A2-CDG. Additional findings included a thin corpus callosum, a pineal cyst, right-sided aortic arch, bilateral vesicoureteral reflux, and central hypothyroidism. Oral D-galactose supplementation was initiated and resulted in subjective improvements in language comprehension, pain responsiveness, and motor function, although no improvement in seizures was observed. Conclusions. This casa may expand the phenotypic spectrum of SLC35A2-CDG by describing bilateral patellar luxation and perineal dysmorphism as potentially novel clinical features, along with a previously unreported pathogenic variant. Recognition of such unique features is crucial for improving our clinical understanding of this rare disorder, guiding differential diagnosis, and contributing to a more refined characterization of genotype–phenotype correlations.
- Open Access
- 16 October 2026
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 9, 1-8
JUVENİL DERMATOMİYOZİTLİ HASTALARIN KLİNİK, LABORATUVAR VE TEDAVİ ÖZELLİKLERİ: TEK MERKEZ DENEYİMİ
Amaç: Juvenil dermatomiyozit (JDM) tanısıyla izlenen hastaların demografik, klinik, laboratuvar, tedavi ve izlem özelliklerinin değerlendirilmesi amaçlandı. Yöntem: Haziran–Aralık 2025 döneminde Kocaeli Üniversitesi Çocuk Sağlığı ve Hastalıkları AD, Çocuk Nörolojisi ve Çocuk Romatolojisi kliniklerinde izlenen, Bohan–Peter veya 2017 EULAR/ACR sınıflama kriterlerini karşılayan 15 JDM hastasının kayıtları retrospektif olarak incelendi. Demografik veriler, klinik ve laboratuvar bulguları, otoantikor profilleri, görüntüleme sonuçları, tedaviler ve klinik sonuçlar değerlendirildi. Kas gücü ve fonksiyonu Çocukluk Çağı Miyozit Değerlendirme Ölçeği (CMAS) ile değerlendirildi. Bulgular: Hastaların %80’i kızdı; ortanca tanı yaşı 7 (2–12) yıl, takip süresi 37 (6–91) aydı. Gottron papülleri %100, fotosensitivite %86,7 ve heliotrop döküntü %73,3 oranında saptandı. Kas-iskelet sistemi tutulumu %86,7, kas enzim yüksekliği %80, antinükleer antikor pozitifliği %60 oranındaydı. Miyozit-ilişkili antikorlar incelenen 14 hastanın 4’ünde, miyozit-spesifik antikorlar 13 hastanın 9’unda pozitifti. Kardiyak tutulum %26,7, akciğer tutulumu %6,7 oranında bulundu. Kas manyetik rezonans görüntülemesinde (MRG) 15 hastanın 13’ünde miyozit bulguları saptanırken, elektromiyografi yapılan iki hastada miyopatik bulgu izlenmedi. Tüm hastalar sistemik kortikosteroid, %86,7’si metotreksat ve %53,3’ü intravenöz immünglobulin aldı. İzlemde herhangi bir zamanda remisyon %80, son vizitte remisyon %66,7 oranındaydı; mortalite gözlenmedi. Sonuç: Tek merkez verilerimiz, JDM’nin pediatrik popülasyonda klasik mukokutanöz bulgularla prezente olduğunu ve kas MRG’nin aktif inflamasyonun gösterilmesinde duyarlı ve invaziv olmayan bir tanısal araç olduğunu göstermektedir. Hastaların çoğunun erken dönemde steroid–metotreksat temelli tedavi aldığı kohortumuzda yüksek remisyon oranları gözlenmiştir.
- 16 October 2026
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 9, 1-8
Open AccessJUVENİL DERMATOMİYOZİTLİ HASTALARIN KLİNİK, LABORATUVAR VE TEDAVİ ÖZELLİKLERİ: TEK MERKEZ DENEYİMİ
Amaç: Juvenil dermatomiyozit (JDM) tanısıyla izlenen hastaların demografik, klinik, laboratuvar, tedavi ve izlem özelliklerinin değerlendirilmesi amaçlandı. Yöntem: Haziran–Aralık 2025 döneminde Kocaeli Üniversitesi Çocuk Sağlığı ve Hastalıkları AD, Çocuk Nörolojisi ve Çocuk Romatolojisi kliniklerinde izlenen, Bohan–Peter veya 2017 EULAR/ACR sınıflama kriterlerini karşılayan 15 JDM hastasının kayıtları retrospektif olarak incelendi. Demografik veriler, klinik ve laboratuvar bulguları, otoantikor profilleri, görüntüleme sonuçları, tedaviler ve klinik sonuçlar değerlendirildi. Kas gücü ve fonksiyonu Çocukluk Çağı Miyozit Değerlendirme Ölçeği (CMAS) ile değerlendirildi. Bulgular: Hastaların %80’i kızdı; ortanca tanı yaşı 7 (2–12) yıl, takip süresi 37 (6–91) aydı. Gottron papülleri %100, fotosensitivite %86,7 ve heliotrop döküntü %73,3 oranında saptandı. Kas-iskelet sistemi tutulumu %86,7, kas enzim yüksekliği %80, antinükleer antikor pozitifliği %60 oranındaydı. Miyozit-ilişkili antikorlar incelenen 14 hastanın 4’ünde, miyozit-spesifik antikorlar 13 hastanın 9’unda pozitifti. Kardiyak tutulum %26,7, akciğer tutulumu %6,7 oranında bulundu. Kas manyetik rezonans görüntülemesinde (MRG) 15 hastanın 13’ünde miyozit bulguları saptanırken, elektromiyografi yapılan iki hastada miyopatik bulgu izlenmedi. Tüm hastalar sistemik kortikosteroid, %86,7’si metotreksat ve %53,3’ü intravenöz immünglobulin aldı. İzlemde herhangi bir zamanda remisyon %80, son vizitte remisyon %66,7 oranındaydı; mortalite gözlenmedi. Sonuç: Tek merkez verilerimiz, JDM’nin pediatrik popülasyonda klasik mukokutanöz bulgularla prezente olduğunu ve kas MRG’nin aktif inflamasyonun gösterilmesinde duyarlı ve invaziv olmayan bir tanısal araç olduğunu göstermektedir. Hastaların çoğunun erken dönemde steroid–metotreksat temelli tedavi aldığı kohortumuzda yüksek remisyon oranları gözlenmiştir.
- 3 August 2026
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 48 (8) , e439-e445
Central Nervous System Immune Reconstitution Inflammatory Syndrome During Neutrophil Recovery in Pediatric Acute Myeloid Leukemia: A Clinical and Laboratory Observation
Background: Central nervous system (CNS) immune reconstitution inflammatory syndrome (IRIS) is well characterized in HIV but exceedingly rare in pediatric hematologic malignancies. Observation: An 11.5-year-old girl with acute myeloid leukemia (AML) and probable invasive pulmonary mold infection developed an expansive right parieto-occipital lesion with a 14 mm midline shift during neutrophil recovery. Evaluation excluded leukemic infiltration and active infection. Probable CNS IRIS was diagnosed; dexamethasone with continued antifungal therapy produced rapid clinical and radiologic recovery, with sustained AML remission at 29 months. Conclusions: CNS IRIS should be considered in pediatric AML with unexplained neurological deterioration during neutrophil recovery; timely corticosteroid therapy can be life-saving.
- 3 August 2026
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 48 (8) , e439-e445
Central Nervous System Immune Reconstitution Inflammatory Syndrome During Neutrophil Recovery in Pediatric Acute Myeloid Leukemia: A Clinical and Laboratory Observation
Background: Central nervous system (CNS) immune reconstitution inflammatory syndrome (IRIS) is well characterized in HIV but exceedingly rare in pediatric hematologic malignancies. Observation: An 11.5-year-old girl with acute myeloid leukemia (AML) and probable invasive pulmonary mold infection developed an expansive right parieto-occipital lesion with a 14 mm midline shift during neutrophil recovery. Evaluation excluded leukemic infiltration and active infection. Probable CNS IRIS was diagnosed; dexamethasone with continued antifungal therapy produced rapid clinical and radiologic recovery, with sustained AML remission at 29 months. Conclusions: CNS IRIS should be considered in pediatric AML with unexplained neurological deterioration during neutrophil recovery; timely corticosteroid therapy can be life-saving.
- 17 July 2026
- Published by Academician Publishing
- p. 385-416
Çocukluk Çağı Başağrılarında Güncel ve Gelecek Tedaviler
- 17 July 2026
- Published by Academician Publishing
- p. 385-416
Çocukluk Çağı Başağrılarında Güncel ve Gelecek Tedaviler
- Open Access
- 28 April 2026
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 40 (3) , 1680-1695
NLRP3 and RANK-RANKL-OPG Pathway-related Gene Expression Levels in Children With Autism Spectrum Disorder
Altered glial function, and increased proinflammatory cytokines are associated with behavioral and cognitive problems seen in autism spectrum disorder (ASD). In this study, we aimed to investigate the neuroinflammatory process in ASD and the relationship between neuroinflammatory markers and the severity of autism symptoms. We evaluated the gene expression levels of NLRP-3 and RANK-RANKL-OPG inflammasome pathways in 50 children with ASD (AC), 34 typically developing siblings (HSAC), and 16 healthy controls (HC) and the correlation between gene expression levels and severity of neuro-psychiatric dysfunctions in ASD. All children were aged 3-18 years. The severity of autism core symptoms and neurologic dysfunction was determined by the Childhood Autism Rating Scale (CARS), Turkish Communication Development Inventory (TCDI), Dunn's Sensory Profile, Adolescents/Adults Sensory Profile and Clinical Observation of Neuromotor Performance, and the scores were correlated with gene expression levels. Up-regulation was observed in all genes (IL-1β, Casp1, NLRP3, NLRP1, TNFRSF11B, TNFRSF11A, and TNFSF11) in the ASD group, but only the difference between the AC and HC groups was statistically significant for TNFRSF11B, TNFRSF11A, and TNFSF11. There were significant correlations in the linguistic and cognitive skills, sensory profile, and neuromotor performance domains for genes associated with both inflammatory pathways. This is the first study showing that the RANK-RANKL-OPG pathway is active in ASD cases. Our results emphasize the harmful influence of the RANK-RANKL-OPG and NLRP3 inflammasome complexes on neurologic development.
- 28 April 2026
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 40 (3) , 1680-1695
Open AccessNLRP3 and RANK-RANKL-OPG Pathway-related Gene Expression Levels in Children With Autism Spectrum Disorder
Altered glial function, and increased proinflammatory cytokines are associated with behavioral and cognitive problems seen in autism spectrum disorder (ASD). In this study, we aimed to investigate the neuroinflammatory process in ASD and the relationship between neuroinflammatory markers and the severity of autism symptoms. We evaluated the gene expression levels of NLRP-3 and RANK-RANKL-OPG inflammasome pathways in 50 children with ASD (AC), 34 typically developing siblings (HSAC), and 16 healthy controls (HC) and the correlation between gene expression levels and severity of neuro-psychiatric dysfunctions in ASD. All children were aged 3-18 years. The severity of autism core symptoms and neurologic dysfunction was determined by the Childhood Autism Rating Scale (CARS), Turkish Communication Development Inventory (TCDI), Dunn's Sensory Profile, Adolescents/Adults Sensory Profile and Clinical Observation of Neuromotor Performance, and the scores were correlated with gene expression levels. Up-regulation was observed in all genes (IL-1β, Casp1, NLRP3, NLRP1, TNFRSF11B, TNFRSF11A, and TNFSF11) in the ASD group, but only the difference between the AC and HC groups was statistically significant for TNFRSF11B, TNFRSF11A, and TNFSF11. There were significant correlations in the linguistic and cognitive skills, sensory profile, and neuromotor performance domains for genes associated with both inflammatory pathways. This is the first study showing that the RANK-RANKL-OPG pathway is active in ASD cases. Our results emphasize the harmful influence of the RANK-RANKL-OPG and NLRP3 inflammasome complexes on neurologic development.
- 23 April 2026
- Published by Adiyaman University in Adıyaman Üniversitesi Sosyal Bilimler Enstitüsü Dergisi
- No. 52,p. 712-740
KUZEY KAFKASYA’DAKİ ÇATIŞMALARDA DİNİ VE ETNİK GRUPLARIN ROLÜ
Avrupa ve Asya’daki Kafkas bölgesinin bir bölümüdür. Güney Kafkasya dünyada insan çeşitliliğinin en fazla olduğu bölgelerden biridir. Kafkasya’nın Rusya’ya bağlı ya da muhtar yapılı olan bölümü ile Rusya’dan ayrı olan yönetimlerin egemenliğindeki bölümü ayrı ayrı isimlendirilmektedir. Rusya tarafına Kuzey Kafkasya, Rusya’nın dışında kalanı ise Güney Kafkasya diye adlandırılır. Aslında Kuzey Güney ayrımını Kafkas Sıradağlarına göre de yapabilmek imkânı bulunmaktadır. Bu dağların Kuzeyi ve Güneyi diye de bölgeyi ayıran yaklaşımlar mevcuttur.Biz de, etnolojik meseleler bakımından Kuzey Kafkasya’nın Güney Kafkasya’ya göre biraz daha öne çıkan karakteristik vasıfları bulunduğundan, bu ayrım konusuna çalışmamızda yer vermiş olduk. Bu kadar çok çeşitli insan gurubunun varlığı iklimlerin dolayısıyla coğrafyaların geçiş güzergahı olan bu dünya bölgesini insanların da geçiş bölgesi olarak adlandırmalarını gerekli kılmaktadır.
- 23 April 2026
- Published by Adiyaman University in Adıyaman Üniversitesi Sosyal Bilimler Enstitüsü Dergisi
- No. 52,p. 712-740
KUZEY KAFKASYA’DAKİ ÇATIŞMALARDA DİNİ VE ETNİK GRUPLARIN ROLÜ
Avrupa ve Asya’daki Kafkas bölgesinin bir bölümüdür. Güney Kafkasya dünyada insan çeşitliliğinin en fazla olduğu bölgelerden biridir. Kafkasya’nın Rusya’ya bağlı ya da muhtar yapılı olan bölümü ile Rusya’dan ayrı olan yönetimlerin egemenliğindeki bölümü ayrı ayrı isimlendirilmektedir. Rusya tarafına Kuzey Kafkasya, Rusya’nın dışında kalanı ise Güney Kafkasya diye adlandırılır. Aslında Kuzey Güney ayrımını Kafkas Sıradağlarına göre de yapabilmek imkânı bulunmaktadır. Bu dağların Kuzeyi ve Güneyi diye de bölgeyi ayıran yaklaşımlar mevcuttur.Biz de, etnolojik meseleler bakımından Kuzey Kafkasya’nın Güney Kafkasya’ya göre biraz daha öne çıkan karakteristik vasıfları bulunduğundan, bu ayrım konusuna çalışmamızda yer vermiş olduk. Bu kadar çok çeşitli insan gurubunun varlığı iklimlerin dolayısıyla coğrafyaların geçiş güzergahı olan bu dünya bölgesini insanların da geçiş bölgesi olarak adlandırmalarını gerekli kılmaktadır.
- Open Access
- 13 April 2026
- Published by Elsevier in SSRN Electronic Journal
Brain Volumetric Changes in Pediatric Seronegative Autoimmune Encephalitis: A Case-Control Study
Seronegative autoimmune encephalitis (SNAE) is an increasingly recognized entity in pediatric neurology, yet quantitative neuroimaging data remain scarce. This study aimed to evaluate regional brain volumetric differences between children diagnosed with SNAE and age- and sex-matched healthy controls using automated MRI volumetry. Fifteen children with SNAE (median age 12 years; 9 males, 6 females) and 45 age- and sex-matched healthy controls were enrolled. Three-dimensional T1-weighted MRI data were processed using the volBrain automated brain volumetry pipeline. Patients with SNAE demonstrated significantly reduced volumes in whole brain (p = 0.005), grey matter (p = 0.001), thalamus (p = 0.001), putamen (p < 0.001), caudate (p = 0.002), pallidum (p < 0.001), hippocampus (p = 0.027), and cerebellum (p < 0.001) compared with healthy controls. White matter, amygdala, and brainstem volumes did not differ significantly. ROC analysis revealed pallidum volume as the best discriminator (AUC = 0.889), followed by putamen (AUC = 0.884) and cerebellum (AUC = 0.810). In multivariate logistic regression after LASSO feature selection, cerebellum volume was the sole independent predictor (adjusted OR = 12.14, p = 0.030). Children with SNAE exhibit widespread subcortical and cerebellar volume loss. Pallidum volume demonstrates the highest discriminative ability and may serve as a potential quantitative imaging biomarker. These findings suggest that SNAE leads to significant structural brain changes even in the absence of identifiable autoantibodies.
- 13 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessBrain Volumetric Changes in Pediatric Seronegative Autoimmune Encephalitis: A Case-Control Study
Seronegative autoimmune encephalitis (SNAE) is an increasingly recognized entity in pediatric neurology, yet quantitative neuroimaging data remain scarce. This study aimed to evaluate regional brain volumetric differences between children diagnosed with SNAE and age- and sex-matched healthy controls using automated MRI volumetry. Fifteen children with SNAE (median age 12 years; 9 males, 6 females) and 45 age- and sex-matched healthy controls were enrolled. Three-dimensional T1-weighted MRI data were processed using the volBrain automated brain volumetry pipeline. Patients with SNAE demonstrated significantly reduced volumes in whole brain (p = 0.005), grey matter (p = 0.001), thalamus (p = 0.001), putamen (p < 0.001), caudate (p = 0.002), pallidum (p < 0.001), hippocampus (p = 0.027), and cerebellum (p < 0.001) compared with healthy controls. White matter, amygdala, and brainstem volumes did not differ significantly. ROC analysis revealed pallidum volume as the best discriminator (AUC = 0.889), followed by putamen (AUC = 0.884) and cerebellum (AUC = 0.810). In multivariate logistic regression after LASSO feature selection, cerebellum volume was the sole independent predictor (adjusted OR = 12.14, p = 0.030). Children with SNAE exhibit widespread subcortical and cerebellar volume loss. Pallidum volume demonstrates the highest discriminative ability and may serve as a potential quantitative imaging biomarker. These findings suggest that SNAE leads to significant structural brain changes even in the absence of identifiable autoantibodies.
- Open Access
- 11 March 2026
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 68 (2) , 1-7
Leber hereditary optic neuropathy (LHON) in a 6-year-old boy with a transient spinal cord lesion
Background. Leber hereditary optic neuropathy (LHON) is a maternally inherited mitochondrial disorder that predominantly manifests as bilateral, painless vision loss in young males. While traditionally associated with the optic nerves, a subset of patients exhibits additional neurological symptoms, referred to as LHON-plus syndrome. Involvement of the spinal cord is uncommon, particularly among the pediatric population, and may result in diagnostic challenges, potentially leading to confusion regarding acquired demyelinating diseases. Case Presentation. We report a 6-year-old boy with near-complete vision loss in the right eye and blurred vision in the left eye. Demyelinating diseases were suspected in the case of acute bilateral optic neuropathy. Cranial and orbital magnetic resonance imaging (MRI) showed no demyelinating lesions, whereas spinal MRI revealed a T2-hyperintense lesion at the C3–C6 levels. Due to unresponsiveness to conventional treatment for demyelinating diseases, genetic testing confirmed the homoplasmic m.11778G>A variant in NADH dehydrogenase subunit 4 (MT-ND4), establishing an LHON diagnosis. Spinal cord involvement supported the LHON-plus syndrome classification. Idebenone therapy was initiated, and follow-up was scheduled. During the 1.5-year follow-up, right eye visual loss persisted, while the left eye showed gradual vision decline. A second spinal MRI performed at 6 months showed complete resolution of the previous lesion without new lesions. Conclusion. Since optic neuropathy and spinal cord involvement typically indicate demyelinating diseases, these should be prioritized in initial evaluation due to their frequency and need for early immunomodulatory treatment. However, spinal cord involvement can occur in mitochondrial diseases, as demonstrated in this case. The presence of a transient and asymptomatic spinal cord lesion in this patient expands the recognized spectrum of central nervous system involvement in LHON. Therefore, LHON-plus syndrome should be considered when spinal cord involvement accompanies optic neuropathy after excluding other demyelinating diseases.
- 11 March 2026
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 68 (2) , 1-7
Open AccessLeber hereditary optic neuropathy (LHON) in a 6-year-old boy with a transient spinal cord lesion
Background. Leber hereditary optic neuropathy (LHON) is a maternally inherited mitochondrial disorder that predominantly manifests as bilateral, painless vision loss in young males. While traditionally associated with the optic nerves, a subset of patients exhibits additional neurological symptoms, referred to as LHON-plus syndrome. Involvement of the spinal cord is uncommon, particularly among the pediatric population, and may result in diagnostic challenges, potentially leading to confusion regarding acquired demyelinating diseases. Case Presentation. We report a 6-year-old boy with near-complete vision loss in the right eye and blurred vision in the left eye. Demyelinating diseases were suspected in the case of acute bilateral optic neuropathy. Cranial and orbital magnetic resonance imaging (MRI) showed no demyelinating lesions, whereas spinal MRI revealed a T2-hyperintense lesion at the C3–C6 levels. Due to unresponsiveness to conventional treatment for demyelinating diseases, genetic testing confirmed the homoplasmic m.11778G>A variant in NADH dehydrogenase subunit 4 (MT-ND4), establishing an LHON diagnosis. Spinal cord involvement supported the LHON-plus syndrome classification. Idebenone therapy was initiated, and follow-up was scheduled. During the 1.5-year follow-up, right eye visual loss persisted, while the left eye showed gradual vision decline. A second spinal MRI performed at 6 months showed complete resolution of the previous lesion without new lesions. Conclusion. Since optic neuropathy and spinal cord involvement typically indicate demyelinating diseases, these should be prioritized in initial evaluation due to their frequency and need for early immunomodulatory treatment. However, spinal cord involvement can occur in mitochondrial diseases, as demonstrated in this case. The presence of a transient and asymptomatic spinal cord lesion in this patient expands the recognized spectrum of central nervous system involvement in LHON. Therefore, LHON-plus syndrome should be considered when spinal cord involvement accompanies optic neuropathy after excluding other demyelinating diseases.